101 related articles for article (PubMed ID: 18242614)
1. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Herder C; Illig T; Baumert J; Müller M; Klopp N; Khuseyinova N; Meisinger C; Martin S; Thorand B; Koenig W
Atherosclerosis; 2008 Oct; 200(2):380-8. PubMed ID: 18242614
[TBL] [Abstract][Full Text] [Related]
2. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.
Herder C; Klopp N; Baumert J; Müller M; Khuseyinova N; Meisinger C; Martin S; Illig T; Koenig W; Thorand B
Diabetologia; 2008 Feb; 51(2):276-84. PubMed ID: 17712545
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study.
Karakas M; Koenig W; Zierer A; Herder C; Rottbauer W; Baumert J; Meisinger C; Thorand B
J Intern Med; 2012 Jan; 271(1):43-50. PubMed ID: 21535251
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Koenig W; Khuseyinova N; Baumert J; Thorand B; Loewel H; Chambless L; Meisinger C; Schneider A; Martin S; Kolb H; Herder C
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2745-51. PubMed ID: 17008587
[TBL] [Abstract][Full Text] [Related]
5. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
Herder C; Kolb H; Koenig W; Haastert B; Müller-Scholze S; Rathmann W; Holle R; Thorand B; Wichmann HE
Diabetes Care; 2006 Feb; 29(2):368-71. PubMed ID: 16443889
[TBL] [Abstract][Full Text] [Related]
6. Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002.
Karakas M; Zierer A; Herder C; Baumert J; Meisinger C; Koenig W; Thorand B
Atherosclerosis; 2010 Mar; 209(1):220-5. PubMed ID: 19732895
[TBL] [Abstract][Full Text] [Related]
7. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
Rammos C; Hendgen-Cotta UB; Sobierajski J; Adamczyk S; Hetzel GR; Kleophas W; Dellanna F; Kelm M; Rassaf T
Int J Cardiol; 2013 Oct; 168(6):5249-56. PubMed ID: 23978362
[TBL] [Abstract][Full Text] [Related]
9. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Herder C; Illig T; Baumert J; Müller M; Klopp N; Khuseyinova N; Meisinger C; Poschen U; Martin S; Koenig W; Thorand B
Eur J Endocrinol; 2008 May; 158(5):R1-5. PubMed ID: 18426815
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease.
Ji K; Wang X; Li J; Lu Q; Wang G; Xue Y; Zhang S; Qian L; Wu W; Zhu Y; Wang L; Liao L; Tang J
Biomed Res Int; 2015; 2015():315174. PubMed ID: 25821795
[TBL] [Abstract][Full Text] [Related]
11. Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Herder C; Baumert J; Thorand B; Martin S; Löwel H; Kolb H; Koenig W
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2147-52. PubMed ID: 16825597
[TBL] [Abstract][Full Text] [Related]
12. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor is associated with aneurysmal expansion.
Pan JH; Lindholt JS; Sukhova GK; Baugh JA; Henneberg EW; Bucala R; Donnelly SC; Libby P; Metz C; Shi GP
J Vasc Surg; 2003 Mar; 37(3):628-35. PubMed ID: 12618703
[TBL] [Abstract][Full Text] [Related]
14. Job strain-associated inflammatory burden and long-term risk of coronary events: findings from the MONICA/KORA Augsburg case-cohort study.
Emeny RT; Zierer A; Lacruz ME; Baumert J; Herder C; Gornitzka G; Koenig W; Thorand B; Ladwig KH;
Psychosom Med; 2013 Apr; 75(3):317-25. PubMed ID: 23460721
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events.
Herder C; Peeters W; Zierer A; de Kleijn DP; Moll FL; Karakas M; Roden M; Meisinger C; Thorand B; Pasterkamp G; Koenig W
Eur J Clin Invest; 2012 Mar; 42(3):329-37. PubMed ID: 21950567
[TBL] [Abstract][Full Text] [Related]
16. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
Stein A; Panjwani A; Sison C; Rosen L; Chugh R; Metz C; Bank M; Bloom O
Arch Phys Med Rehabil; 2013 Aug; 94(8):1498-507. PubMed ID: 23618747
[TBL] [Abstract][Full Text] [Related]
17. RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies.
Herder C; Peeters W; Illig T; Baumert J; de Kleijn DP; Moll FL; Poschen U; Klopp N; Müller-Nurasyid M; Roden M; Preuss M; ; Karakas M; Meisinger C; Thorand B; Pasterkamp G; Koenig W; Assimes TL; Deloukas P; Erdmann J; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Schunkert H; Stewart AF
PLoS One; 2011; 6(12):e25734. PubMed ID: 22162987
[TBL] [Abstract][Full Text] [Related]
18. Dietary patterns, subclinical inflammation, incident coronary heart disease and mortality in middle-aged men from the MONICA/KORA Augsburg cohort study.
Meyer J; Döring A; Herder C; Roden M; Koenig W; Thorand B
Eur J Clin Nutr; 2011 Jul; 65(7):800-7. PubMed ID: 21468094
[TBL] [Abstract][Full Text] [Related]
19. Obesity, macrophage migration inhibitory factor, and weight loss.
Church TS; Willis MS; Priest EL; Lamonte MJ; Earnest CP; Wilkinson WJ; Wilson DA; Giroir BP
Int J Obes (Lond); 2005 Jun; 29(6):675-81. PubMed ID: 15795748
[TBL] [Abstract][Full Text] [Related]
20. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
